Browse by Poster Presenter

Skip to main content

ASCPT 2023 Annual Meeting Main banner

Tweets by ASCPT 2023 Annual Meeting

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

K
Kandala, Bhargava

Merck & Co.
PII-024 - TRANSLATIONAL MODEL-BASED META-ANALYSIS - A POWERFUL QUANTITATIVE TOOL IN DEVELOPING VACCINES AGAINST SARS-COV-2 VARIANTS.
Bhargava Kandala
Favorite
Kandasamy, Murugesh

Indiana University
PII-016 - PHARMACOKINETICS OF SHIP1 INHIBITORS IN MICE: COMPARISON OF IN SILICO AND IN VIVO PHARMACOKINETICS.
Murugesh Kandasamy
Favorite
Kapitanov, Georgi

Applied BioMath
PI-095 - BLINATUMOMAB TRIMER FORMATION - INSIGHTS FROM A MECHANISTIC PKPD MODEL ON THE IMPLICATIONS FOR SWITCHING FROM INFUSION TO SUBCUTANEOUS DOSING REGIMEN IN ACUTE LYMPHOBLASTIC LEUKEMIA AND NON-HODGKIN’S LYMPHOMA.
Georgi Kapitanov
Favorite
Kareva, Irina

EMD Serono
PI-073 - INTEGRATED MODEL-BASED ANALYSIS UTILIZING CO-EXPRESSED CHECKPOINT INHIBITOR DATA TO INFORM THE RECOMMENDED DOSE FOR EXPANSION (RDE) OF ANTI-TIGIT MAB M6223.
Irina Kareva
Favorite
Kathman, Steven

Gilead Sciences
PII-076 - POPULATION PHARMACOKINETIC (PK)-PHARMACODYNAMIC (PD) MODELING OF VESATOLIMOD, A TLR7 AGONIST IN DEVELOPMENT FOR HIV CURE.
Steven Kathman
Favorite
Katragadda, Suresh

Sanofi
EP-018 - POPULATION PHARMACOKINETIC ANALYSIS OF RILZABRUTINIB IN HEALTHY SUBJECTS AND PATIENTS WITH PEMPHIGUS.
Suresh Katragadda
Favorite
Kaushal, Neeraj

Moderna Therapeutics, Inc.
PI-054 - DEVELOPMENT OF A PHARMACOKINETIC-PHARMACODYNAMIC MODEL FOR MRNA-0184, AN INVESTIGATIONAL MRNA THERAPEUTIC ENCODING HUMAN RELAXIN-2-VLK FOR THE TREATMENT OF HEART FAILURE.
Neeraj Kaushal
Favorite
Khwarg, Juyoung

Seoul National University College of Medicine and Hospital
PII-069 - PHARMACOKINETIC COMPARISON BETWEEN A FIXED-DOSE COMBINATION OF ATORVASTATIN/OMEGA-3 AND THE CORRESPONDING LOOSE COMBINATION IN HEALTHY KOREAN SUBJECTS.
Juyoung Khwarg
Favorite
Killam, Shayna

University of Montana
PT-029 - BUILDING A TELEHEALTH PHARMACOGENETIC TESTING PROGRAM IN RURAL AND PEDIATRIC PSYCHIATRY.
Shayna Killam
Favorite
Kim, Byungwook

Seoul National University Hospital
PII-073 - PHARMACOKINETICS AND PHARMACODYNAMICS OF EVOGLIPTIN IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS.
Byungwook Kim
Favorite
Kim, Dong Hyun

Kyung Hee University
PI-094 - A QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL OF SEPSIS-INDUCED AUGMENTED RENAL CLEARANCE.
Dong Hyun Kim
Favorite
Kim, Ha-Yeon

Chungbuk National University Hospital
PI-049 - COMPARISON OF THE ACID SUPPRESSION EFFECTS BETWEEN LOW-DOSE ESOMEPRAZOLE AND FAMOTIDINE IN HEALTHY SUBJECTS.
Ha-Yeon Kim
Favorite
PII-066 - PHARMACOKINETIC AND PHARMACODYNAMIC CHARACTERISTICS OF PELUBIPROFEN TROMETHAMINE VERSUS PELUBIPROFEN IN HEALTHY SUBJECTS.
Ha-Yeon Kim
Favorite
Kim, Hyun Chul

Seoul National University College of Medicine and Hospital
PII-018 - THE PHARMACODYNAMICS, PHARMACOKINETICS, AND SAFETY OF VUTIGLABRIDIN, A SYNTHETIC GLABRIDIN DERIVATIVE, AFTER MULTIPLE ADMINISTRATION IN OBESE SUBJECTS.
Hyun Chul Kim
Favorite
Kim, Jae Hoon

Chungnam National University Hospital
EP-031 - PHARMACOKINETIC INTERACTION OF OMEGA-3 FATTY ACID 4 G AND ATORVASTATIN 40 MG.
Jae Hoon Kim
Favorite
Kim, Kyeongmin

The Ohio State University
PI-070 - EXPOSURE-TARGETED MELPHALAN DOSING INDIVIDULIZATION IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS TRANSPLANT.
Kyeongmin Kim
Favorite
Kim, Ryunha

Inje University
EP-013 - DEVELOPMENT OF POPULATION PHARMACOKINETICS MODEL OF PYRAZINAMIDE AND OPTIMAL DOSE RECOMMENDATION FOR ELDERLY WITH DIABETES MELLITUS IN KOREAN TUBERCULOSIS PATIENTS.
Ryunha Kim
Favorite
Kim, Yoon Jin

Seoul National University Hospital
PII-015 - PHARMACOKINETICS AND PHARMACODYNAMICS OF ENAVOGLIFLOZIN, AN SGLT-2 INHIBITOR, IN TYPE 2 DIABETES PATIENTS WITH IMPAIRED RENAL FUNCTION.
Yoon Jin Kim
Favorite
Klomp, Sylvia

Leiden University Medical Center
PII-047 - INFLAMMATION DRIVEN INHIBITION OF CYP2C19 METABOLISM OF VORICONAZOLE IN THE TREATMENT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.
Sylvia Klomp
Favorite
Koh, JaeEun

Seoul National University College of Medicine and Hospital
PI-045 - COMPARATIVE PHARMACOKINETICS BETWEEN DA-2811, A DAPAGLIFLOZIN PRODRUG FORMULATION, AND CONVENTIONAL DAPAGLIFLOZIN TABLET.
JaeEun Koh
Favorite
Koldeweij, Charlotte

Radboud University Medical Center
PI-090 - PERCEIVED BARRIERS AND FACILITATORS FOR MODEL-INFORMED DOSING IN PREGNANCY AMONG HEALTHCARE PRACTITIONERS AND PREGNANT WOMEN: A QUALITATIVE STUDY.
Charlotte Koldeweij
Favorite
Koleske, Megan

University of California, San Francisco
LB-006 - EFFECTS OF ANTIOXIDANTS IN DRUGS PRODUCTS ON INTESTINAL DRUG TRANSPORTERS.
Megan Koleske
Favorite
Kotani, Naoki

Chugai Pharmaceutical Co., Ltd.
PII-042 - TRANSLATABILITY OF IN VITRO POTENCY TO CLINICALLY EFFICACIOUS EXPOSURE FOR MOLECULARLY TARGETED SMALL MOLECULE ONCOLOGY DRUGS.
Naoki Kotani
Favorite
Kurata, Akifumi

Daiichi Sankyo
PI-010 - A DDI STUDY TO EVALUATE THE EFFECT OF MULTIPLE ORAL ADMINISTRATION OF RIFAMPICIN ON THE PHARMACOKINETICS OF VALEMETOSTAT IN HEALTHY PARTICIPANTS.
Akifumi Kurata
Favorite
Kyler, Kathryn

Children's Mercy Kansas City
PT-005 - MAJOR POTENTIAL DRUG-DRUG INTERACTIONS AMONG MEDICAID-INSURED CHILDREN IN THE OUTPATIENT SETTING.
Kathryn Kyler
Favorite